Supplementary Table S2 from Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

<p>Supplementary Table S2. PDX models minimal information standard (PDX-MI).</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Arun Kanakkanthara (14937731) (author)
Diğer Yazarlar:	Xiaonan Hou (736827) (author), Thomas L. Ekstrom (14937737) (author), Valentina Zanfagnin (15203306) (author), Amelia M. Huehls (14904464) (author), Rebecca L. Kelly (15203309) (author), Husheng Ding (14911926) (author), Melissa C. Larson (14969062) (author), George Vasmatzis (69257) (author), Ann L. Oberg (14937746) (author), Scott H. Kaufmann (14937749) (author), Aaron S. Mansfield (15033804) (author), S. John Weroha (7907816) (author), Larry M. Karnitz (13208232) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Chemotherapy Combination chemotherapy DNA Damage and Repair DNA repair Drug Mechanisms Gynecological Cancers Ovarian cancer Preclinical Models
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller